XDH and Tumor Lysis Syndrome: Allopurinol, a well-established xanthine oxidase inhibitor long-used to treat hyperuricemia in patients with gout or tumor lysis syndrome (Adeyinka and Bashir, 2024), has demonstrated broader vascular benefits.